Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03373045 · ClinicalTrials.gov registry record

Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)

A clinical trial of Asthma, sponsored by AstraZeneca.

Completed
Registry status
18
Enrollment target
20
Study locations

NCT03373045 is a study of Asthma that has completed, run by AstraZeneca. The registered enrollment target is 18 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03373045, a study of Asthma, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
18 participants
Enrollment target
20
Study locations

Study Summary

The CHRONICLE Study is a multi-center, non-interventional, prospective cohort study of adults with severe asthma who do not achieve control with high-dose inhaled corticosteroid (ICS) therapy with additional controllers and/or require systemic corticosteroid or monoclonal antibody therapy. Data will be collected from the healthcare provider in a uniform manner for every patient enrolled using an electronic case report form (eCRF). Data will be collected monthly from patients via web-based surveys. Patients will be followed until study discontinuation or the patient withdraws from the study or death, whichever occurs first. The expectation is that patients will be followed for a period of at least 3 years.

Conditions Studied

Asthma

Study Locations (20)

California

  • Research Site - Bakersfield
  • Research Site - Loma Linda
  • Research Site - Los Angeles
  • Research Site - Mission Viejo
  • Research Site - Modesto
  • Research Site - Redondo Beach
  • Research Site - Riverside
  • Research Site - Roseville
  • Research Site - Sacramento
  • Research Site - San Diego
  • Research Site - San Diego
  • Research Site - San Diego
  • Research Site - Santa Monica
  • Research Site - Studio City

Alabama

  • Research Site - Birmingham
  • Research Site - Birmingham
  • Research Site - Hoover

Arizona

  • Research Site - Gilbert
  • Research Site - Peoria

Arkansas

  • Research Site - Little Rock

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2018-02-27
Est. Completion 2025-02-14

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03373045

The ClinicalTrials.gov registry entry for NCT03373045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.

NCT03373045 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT03373045 about?

NCT03373045 is a clinical study titled "Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)". The CHRONICLE Study is a multi-center, non-interventional, prospective cohort study of adults with severe asthma who do not achieve control with high-dose inhaled corticosteroid (ICS) therapy with additional controllers and/or require systemic corticosteroid or monoclonal antibody therapy. Data will...

What is the current status of trial NCT03373045?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2018-02-27. Estimated completion is 2025-02-14.

What conditions does trial NCT03373045 study?

This clinical trial studies the following conditions: Asthma.

Who is sponsoring clinical trial NCT03373045?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03373045 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.